Histologic subtype included NOS/other (59.9%), followed by superficial spreading melanoma (SSM; 17.4%), acral lentiginous melanoma (ALM; 14.1%), and nodular melanoma (NM; 8.7%). Asian Americans (AAs) are often combined with Pacific Islanders (PIs) for cutaneous melanoma studies,[[1]] although evidence indicates that these groups respond differently to UV exposure, an important melanoma risk factor.[3] Little is known about clinical presentation and survival predictors specifically in AA with melanoma, which this study explores. This Cox regression model was adjusted for the following categorical variables: age, primary site, insurance status, Charlson-Deyo comorbidity score, stage at diagnosis, melanoma histology, ulceration, surgery, systemic therapy (immunotherapy and/or chemotherapy, which were combined because of small numbers), radiation. [Extracted from the article]